1 Min Read
Sept 11 (Reuters) - Miragen Therapeutics Inc
* Miragen Therapeutics presents new MRG-201 preclinical data for Inhaled Microrna-29 Mimic Targeting Pulmonary Fibrosis Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.